INTELIPHAGE
Press
O.A.G. (UK) 
O.A.G. (UK)
Inteliphage, a pioneer in the development of innovative, personalized and sustainable phage-based therapy solutions for tackling superbugs and antimicrobial resistance.
L’Écho
L’Écho
Inteliphage named most innovative start-up in life sciences in Europe at tenth edition of BioFIT
La Libre
La Libre
Inteliphage enters into an innovative and ambitious collaboration with the Belgian Army
L’Écho
L’Écho
Inteliphage raises a first tranche of €3 million: in preparation for its IPO, which has been brought forward to the end of 2022, Vésale Bioscience has raised a first tranche of funds from private investors.
